Suppr超能文献

蛋白酪氨酸磷酸酶非受体型22(Ptpn22)通过上调糖皮质激素诱导的肿瘤坏死因子受体(GITR)来调节调节性T细胞的稳态。

Ptpn22 Modifies Regulatory T Cell Homeostasis via GITR Upregulation.

作者信息

Nowakowska Dominika J, Kissler Stephan

机构信息

Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215.

Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215

出版信息

J Immunol. 2016 Mar 1;196(5):2145-52. doi: 10.4049/jimmunol.1501877. Epub 2016 Jan 25.

Abstract

PTPN22 gene variation associates with multiple autoimmune diseases, including type 1 diabetes and rheumatoid arthritis. Loss of function studies have demonstrated that PTPN22 impinges on the homeostatic behavior of regulatory T (Treg) cells, a lineage critical for immune tolerance. The frequency and absolute number of Treg cells is increased in Ptpn22-deficient mice, but the mechanism driving this increase is unknown. In this study, we show that Ptpn22 knockdown (KD) promoted the expansion of the Treg cell compartment by upregulating the glucocorticoid-induced TNFR family-related protein (GITR) and increasing GITR signaling. Ptpn22 KD did not accelerate cell division but instead prolonged Treg cell survival, as measured by a decrease in the frequency of apoptotic Treg cells. Loss of Ptpn22 caused a concomitant increase in the proportion of CD44(hi)CD62L(lo) effector Treg cells, at the expense of CD44(lo)CD62L(hi) central Treg cells. The increase in Treg cell numbers, but not their differentiation toward an effector phenotype, was dependent on GITR signaling, because blockade of GITR ligand prevented Treg cell expansion caused by Ptpn22 KD. These findings indicate that GITR plays a key role in regulating the overall size of the Treg cell pool. Our results suggest that the size and composition of the Treg cell compartment are independently controlled and have implications for the design of immunotherapies that seek to improve Treg cell function.

摘要

蛋白酪氨酸磷酸酶非受体型22(PTPN22)基因变异与多种自身免疫性疾病相关,包括1型糖尿病和类风湿关节炎。功能丧失研究表明,PTPN22影响调节性T(Treg)细胞的稳态行为,Treg细胞系对免疫耐受至关重要。Ptpn22基因缺陷小鼠中Treg细胞的频率和绝对数量增加,但其增加的机制尚不清楚。在本研究中,我们发现敲低(KD)Ptpn22可通过上调糖皮质激素诱导的肿瘤坏死因子受体家族相关蛋白(GITR)和增加GITR信号来促进Treg细胞区室的扩增。Ptpn22 KD并未加速细胞分裂,而是延长了Treg细胞的存活时间,这可通过凋亡Treg细胞频率的降低来衡量。Ptpn22的缺失导致CD44高表达CD62L低表达效应性Treg细胞比例相应增加,而以CD44低表达CD62L高表达中央Treg细胞为代价。Treg细胞数量的增加而非其向效应细胞表型的分化依赖于GITR信号,因为阻断GITR配体可阻止Ptpn22 KD引起的Treg细胞扩增。这些发现表明,GITR在调节Treg细胞库的总体大小中起关键作用。我们的结果表明,Treg细胞区室的大小和组成是独立控制的,这对旨在改善Treg细胞功能的免疫疗法的设计具有重要意义。

相似文献

1
Ptpn22 Modifies Regulatory T Cell Homeostasis via GITR Upregulation.
J Immunol. 2016 Mar 1;196(5):2145-52. doi: 10.4049/jimmunol.1501877. Epub 2016 Jan 25.
2
GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability.
Cancer Immunol Res. 2013 Nov;1(5):320-31. doi: 10.1158/2326-6066.CIR-13-0086.
3
Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
Cancer Res. 2017 Mar 1;77(5):1108-1118. doi: 10.1158/0008-5472.CAN-16-0797. Epub 2016 Oct 20.
4
Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+ Regulatory T Cells Are Depleted.
J Immunol. 2015 Nov 15;195(10):4721-9. doi: 10.4049/jimmunol.1403076. Epub 2015 Sep 30.
5
A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
J Autoimmun. 2018 Dec;95:77-99. doi: 10.1016/j.jaut.2018.08.007. Epub 2018 Aug 31.
6
CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Eur J Immunol. 2011 Aug;41(8):2269-78. doi: 10.1002/eji.201040943. Epub 2011 Jul 4.
8
10
Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients.
Int Immunol. 2013 Oct;25(10):563-74. doi: 10.1093/intimm/dxt020. Epub 2013 Aug 8.

引用本文的文献

1
CD4 T Cell Subsets and as Novel Biomarkers of Immune Dysregulation in Dilated Cardiomyopathy.
Int J Mol Sci. 2025 Aug 13;26(16):7806. doi: 10.3390/ijms26167806.
2
Mechanism of action of Nrf2 and its related natural regulators in rheumatoid arthritis.
J Orthop Surg Res. 2024 Nov 14;19(1):759. doi: 10.1186/s13018-024-05221-w.
3
Regulation of T Cell Signaling and Immune Responses by PTPN22.
Mol Cell Biol. 2024;44(10):443-452. doi: 10.1080/10985549.2024.2378810. Epub 2024 Jul 22.
4
Relationship between the Ubiquitin-Proteasome System and Autophagy in Colorectal Cancer Tissue.
Biomedicines. 2023 Nov 9;11(11):3011. doi: 10.3390/biomedicines11113011.
5
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions.
iScience. 2023 Sep 12;26(10):107881. doi: 10.1016/j.isci.2023.107881. eCollection 2023 Oct 20.
6
B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions.
Front Cell Dev Biol. 2022 Sep 23;10:991840. doi: 10.3389/fcell.2022.991840. eCollection 2022.
7
Multiple mechanisms for TRAF3-mediated regulation of the T cell costimulatory receptor GITR.
J Biol Chem. 2021 Sep;297(3):101097. doi: 10.1016/j.jbc.2021.101097. Epub 2021 Aug 18.
8
Influence of Allotypes on Innate and Adaptive Immune Function in Health and Disease.
Front Immunol. 2021 Feb 25;12:636618. doi: 10.3389/fimmu.2021.636618. eCollection 2021.
9
The Role of GITR/GITRL Interaction in Autoimmune Diseases.
Front Immunol. 2020 Oct 9;11:588682. doi: 10.3389/fimmu.2020.588682. eCollection 2020.
10
The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future.
Front Endocrinol (Lausanne). 2018 Feb 23;9:51. doi: 10.3389/fendo.2018.00051. eCollection 2018.

本文引用的文献

1
Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling.
J Exp Med. 2015 Jun 29;212(7):1081-93. doi: 10.1084/jem.20142130. Epub 2015 Jun 15.
2
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.
J Autoimmun. 2015 Apr;58:48-58. doi: 10.1016/j.jaut.2015.01.001. Epub 2015 Jan 26.
3
PTPN22: the archetypal non-HLA autoimmunity gene.
Nat Rev Rheumatol. 2014 Oct;10(10):602-11. doi: 10.1038/nrrheum.2014.109. Epub 2014 Jul 8.
5
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.
Lancet Diabetes Endocrinol. 2013 Dec;1(4):295-305. doi: 10.1016/S2213-8587(13)70113-X. Epub 2013 Oct 8.
7
GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability.
Cancer Immunol Res. 2013 Nov;1(5):320-31. doi: 10.1158/2326-6066.CIR-13-0086.
8
CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets.
J Exp Med. 2014 Jan 13;211(1):121-36. doi: 10.1084/jem.20131142. Epub 2013 Dec 30.
9
Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease.
Annu Rev Immunol. 2014;32:83-119. doi: 10.1146/annurev-immunol-032713-120249. Epub 2013 Dec 18.
10
Soluble factors secreted by T cells promote β-cell proliferation.
Diabetes. 2014 Jan;63(1):188-202. doi: 10.2337/db13-0204. Epub 2013 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验